Sheba Medical Center and Enlivex Announce Dosing of the First Patient in Phase I/II Trial Evaluating Allocetra Combined with Chemotherapy in Patients with Peritoneal Metastases Arising from Solid Cancers
Similar Posts
SnapMD’s Tele-Technology Chosen to Serve as the Foundation of The University of San Diego Hahn School of Nursing and Health Science Telehealth Curriculum
The Virtual Care Management (VCM) software platform digitally simulates all phases of care for a virtualized medical clinic SnapMD,…
EarlySense Increases Installed Base by 400% in 2017, Answers Rising Demand as Continuous Monitoring Comes Closer to Standard of Care
EarlySense Solutions Ordered in 2017 will Enable Healthcare Providers to Save More Than $100 Million per Year EarlySense, the market…
